[
  {
    "ts": "2025-11-21T13:00:34+00:00",
    "headline": "This Medical Technology Leader Sees Profit Growth Topping 44%",
    "summary": "The medical technology stock is in a consolidation pattern and testing a key level. The biotech had a beat-and-raise quarter.",
    "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "4e086c27-b37f-3df1-9313-827af5ba162c",
      "content": {
        "id": "4e086c27-b37f-3df1-9313-827af5ba162c",
        "contentType": "STORY",
        "title": "This Medical Technology Leader Sees Profit Growth Topping 44%",
        "description": "",
        "summary": "The medical technology stock is in a consolidation pattern and testing a key level. The biotech had a beat-and-raise quarter.",
        "pubDate": "2025-11-21T13:00:34Z",
        "displayTime": "2025-11-21T13:00:34Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/4e086c27-b37f-3df1-9313-827af5ba162c/this-medical-technology.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4DFBQ9Ovss1qH4kurbDXSw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JlaDjExgRbJnEne6DZDYNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ROG.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T12:41:00+00:00",
    "headline": "PFE's New & Acquired Drugs Drive Non-COVID Comeback as LOE Test Looms",
    "summary": "Pfizer's new and acquired drugs lift non-COVID revenue, with recent launches and Seagen products driving momentum into 2026 despite looming LOEs.",
    "url": "https://finance.yahoo.com/news/pfes-acquired-drugs-drive-non-124100204.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "315ef055-ab2e-322b-befd-e292f7e8f8f0",
      "content": {
        "id": "315ef055-ab2e-322b-befd-e292f7e8f8f0",
        "contentType": "STORY",
        "title": "PFE's New & Acquired Drugs Drive Non-COVID Comeback as LOE Test Looms",
        "description": "",
        "summary": "Pfizer's new and acquired drugs lift non-COVID revenue, with recent launches and Seagen products driving momentum into 2026 despite looming LOEs.",
        "pubDate": "2025-11-21T12:41:00Z",
        "displayTime": "2025-11-21T12:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ffSS19YaoL36xXdlr0Ip4A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mJhhM1.2_VWzkATXxZYL_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfes-acquired-drugs-drive-non-124100204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfes-acquired-drugs-drive-non-124100204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]